- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stargardt Disease 1 in New Zealand
Total 43877 results
-
University at BuffaloCompletedType 1 Diabetes MellitusUnited States
-
Cordis CorporationConor MedsystemsTerminatedCoronary AtherosclerosisBrazil, New Zealand
-
Stony Brook UniversityCompleted
-
State University of New York at BuffaloJuvenile Diabetes Research Foundation; University of GlasgowRecruiting
-
University of ReadingMassey UniversityCompletedHypertensionNew Zealand
-
SurModics, Inc.Active, not recruitingHemodialysis Access FailureAustralia, New Zealand
-
MetaventionCompletedDiabetes | Endocrine, Nutritional and Metabolic Diseases (E00-E89)New Zealand
-
Hackensack Meridian HealthVerizon FoundationSuspendedType 1 Diabetes MellitusUnited States
-
Dartmouth-Hitchcock Medical CenterDartmouth CollegeCompletedType 1 Diabetes MellitusUnited States
-
Elixir Medical CorporationCompletedCoronary Artery DiseaseNew Zealand
-
Efemoral Medical, Inc.RecruitingVascular Diseases | Peripheral Arterial Disease | Stenosis | Femoropopliteal StenosisNew Zealand, Australia
-
Cystetic Medicines, Inc.DevPro BiopharmaRecruitingCystic FibrosisAustralia, New Zealand
-
Crux BiomedicalCompletedPulmonary EmbolismNew Zealand, Australia
-
CorStoneDavid and Lucile Packard FoundationActive, not recruitingMental Health Wellness 1 | Resilience, PsychologicalIndia
-
Medtronic VascularCompletedUncontrolled HypertensionAustralia, New Zealand
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedMucositis | Xerostomia | Radiation Toxicity | Stage III Squamous Cell Carcinoma of the Hypopharynx | Stage III Squamous Cell Carcinoma of the Larynx | Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage III Squamous Cell Carcinoma of the Nasopharynx | Stage III Squamous Cell Carcinoma... and other conditionsUnited States, New Zealand
-
Dicerna Pharmaceuticals, Inc.CompletedKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)Poland, United Kingdom, New Zealand, United States, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
-
PolyActiva Pty LtdCompletedOcular Hypertension | Open Angle GlaucomaNew Zealand
-
Australian and New Zealand Intensive Care Research...Intensive Care Foundation, AustraliaCompletedCritically Ill Adults Ventilated >24 Hours in Intensive CareAustralia, New Zealand
-
Shockwave Medical, Inc.Active, not recruitingPeripheral Arterial DiseaseNew Zealand, Australia
-
Fisher and Paykel HealthcareTerminatedSleep Disordered Breathing | Congestive Heart FailureNew Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
Valneva Austria GmbHCompletedSARS-CoV-2 InfectionNew Zealand, Netherlands
-
Philips Electronics Nederland B.V. acting through...Qserve; Dent Neurologic InstituteCompleted
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
-
University of RochesterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedType 1 Diabetes Mellitus | HypercalciuriaUnited States
-
Jeffrey BluestoneYale UniversityCompleted
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); Juvenile Diabetes...CompletedType 1 Diabetes MellitusUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Verve Therapeutics, Inc.Not yet recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Verve Therapeutics, Inc.Active, not recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Yale UniversityJuvenile Diabetes Research FoundationCompletedHypo-unawareness | Type 1 Diabetes MellitusUnited States
-
Novartis PharmaceuticalsTerminatedType 1 Diabetes MellitusUnited States
-
Lyra TherapeuticsCompleted
-
GlaxoSmithKlineCompletedAsthmaUnited Kingdom, New Zealand
-
Kona Medical Inc.CompletedHypertensionCzech Republic, New Zealand
-
Ellume Pty LtdWithdrawnGroup A Streptococcal InfectionNew Zealand
-
Grifols Therapeutics LLCActive, not recruitingPulmonary Emphysema in Alpha-1 PI DeficiencyUnited States, Australia, Denmark, New Zealand, Estonia, Poland, Russian Federation, Sweden, Brazil, Canada, France, Finland
-
National University Heart Centre, SingaporeAstraZenecaRecruitingAcute Coronary SyndromeAustralia, New Zealand, Singapore
-
Neothetics, IncCompletedThyroid-Related Eye DiseaseAustralia, New Zealand
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Geneos TherapeuticsActive, not recruitingHCCUnited States, New Zealand
-
Fisher and Paykel HealthcareCompletedObstructive Sleep Apnea | Positive Airway Pressure TherapyNew Zealand
-
University of RochesterNot yet recruitingAge-Related Macular Degeneration | Retinitis Pigmentosa | Retinal Dystrophies | Alcohol Use Disorder | Stargardt DiseaseUnited States
-
University of New MexicoCompletedMental Health Wellness 1 | Behavior, Health | CommunityUnited States
-
AtaCor Medical, Inc.CompletedConduction DefectNew Zealand, Paraguay, Czechia
-
AstraZenecaCompletedAsthmaNew Zealand, United Kingdom
-
University of Auckland, New ZealandCounties Manukau Health; Auckland Medical Research Foundation; Auckland District... and other collaboratorsUnknown
-
National Institute of Diabetes and Digestive and...CompletedType 1 Diabetes | Preservation of Insulin Secretion | Newly Diagnosed Type 1 Diabetes | Canakinumab in Type 1 DiabetesUnited States, Canada